Bay Area's Principia Biopharma Scores $765M MS Licensing Deal With Drug Giant Sanofi Post author:Sam Post published:November 8, 2017 Post category:BioPharma Sanofi will write a check for $40 million upfront. Source: BioSpace You Might Also Like SoCal's Evolus Files for $75M IPO January 8, 2018 FDA Advisory Committee Recommends Approval Of Pfizer???s Proposed Biosimilar To Epogen/Procrit Across All Indications May 25, 2017 Athenex, A US-China Cancer Company, Stages $66 Million U.S. IPO June 15, 2017
FDA Advisory Committee Recommends Approval Of Pfizer???s Proposed Biosimilar To Epogen/Procrit Across All Indications May 25, 2017
